Label combines holograms, 2D datamatrix and thermal monitoring
14-Dec-2011
Scriba Nanotecnologie has
launched a miniaturised 2D datamatrix technology that can be
combined with holograms and other reflective surfaces to provide
authentication, cold-chain and traceability features.
"The evolving role of holograms lies in their ability to combine
authentication with detection, which is the reason why some of the
largest pharmaceutical companies have recognised the need to make
holograms an integral part of their anti-counterfeiting
strategies," said Scriba.
The En-Tag technology takes the form of a 2D datamatrix - roughly
one-tenth the size of a typical code but able to hold 20-30 times
the volume of data - that can be printed directly within the body
of any security hologram using a standard laser-marking
process.
The labels are barely visible to the human eye but can be used to
store a wealth of digital data such as company logos, videos, or
drug pedigree information, including the name, dosage form and
strength, expiration date and lot number of a medicine, according
to Scriba. A 1mm² tag can contain around 300 text characters, it
said.
Meanwhile, the tags can also help monitor the pharmaceutical cold
chain by acting as thermal monitoring devices at the unit dose
level, thanks to the integration of a polymer layer that changes
the look of the hologram when a specified temperature threshold is
breached.
"For temperature-sensitive products in particular, such as
biologics, food products, wine, etc., the technology is a
first-in-class security feature with a clear-cut value
proposition," said Dr. Claudio Rota, business development advisor
at Scriba.
"At the pallet level, drug makers have many options when it comes
to ensuring that their temperature-sensitive products are properly
delivered to the end user," added Rota.
"However, none of the existing technologies, including dataloggers,
RFID or insulated shippers can really be used to monitor the
thermal history of each package or blister pack."
Enjoyed this article? Subscribe to our free weekly newsletter here.
© SecuringPharma.com



